On an international level we are exceptionally good at embracing new technology for health diagnostics. The "Laboratory Developed Methods" provision in IANZ/ISO17025 mean new tests can be rapidly adopted (compared with the onerous task of FDA/user programs). Canterbury Health Laboratories have build an entire business in their specialty chemistry and molecular diagnostics units to develop novel methods, get them approved and sell the service to other DHBs.